Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr;5(2):121-7.
doi: 10.1159/000367749. Epub 2016 Mar 17.

Selection Criteria and Current Issues in Liver Transplantation for Hepatocellular Carcinoma

Toshimi Kaido  1
Affiliations
Review

Selection Criteria and Current Issues in Liver Transplantation for Hepatocellular Carcinoma

Toshimi Kaido. Liver Cancer. 2016 Apr.

Abstract

Liver transplantation (LT) is an ideal treatment for hepatocellular carcinoma (HCC) because it not only resects HCCs but it also replaces the underlying damaged liver with normal tissue. However, the selection criteria are still a matter of debate. After the introduction of the Milan criteria, some expanded criteria focusing on tumor size and number have been proposed. In addition, new expanded criteria considering tumor biology have been proposed using tumor markers and (18)F-fluorodeoxyglucose positron emission tomography. This review summarizes the selection criteria in LT for HCC and introduces current issues focusing on the treatment for hepatitis C virus infection and the significance of sarcopenia in this field.

Keywords: Direct-acting antiviral agents; Expanded criteria; Hepatocellular carcinoma; Liver transplantation; Sarcopenia.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Overall survival rates according to skeletal muscle mass in patients undergoing LDLT.
Fig. 2
Fig. 2
Overall survival rates (a) and recurrence-free survival rates (b) after hepatectomy for HCC according to preoperative IMAC.
See this image and copyright information in PMC

References

    1. Chan SC. Liver transplantation for hepatocellular carcinoma. Liver Cancer. 2013;2:338–344. - PMC - PubMed
    1. Akamatsu N, Sugawara Y, Kokudo N. Living donor liver transplantation for patients with hepatocellular carcinoma. Liver Cancer. 2014;3:108–118. - PMC - PubMed
    1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699. - PubMed
    1. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant. 2007;7:2587–2596. - PubMed
    1. Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis. 2007;25:310–312. - PubMed

LinkOut - more resources